|
ZNF587 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.678790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.173500E-02 |
| Normal-vs-Stage2 |
2.708800E-01 |
| Normal-vs-Stage3 |
7.231200E-01 |
| Normal-vs-Stage4 |
6.978800E-01 |
| Stage1-vs-Stage2 |
9.313200E-01 |
| Stage1-vs-Stage3 |
2.937600E-01 |
| Stage1-vs-Stage4 |
3.914000E-01 |
| Stage2-vs-Stage3 |
4.613000E-01 |
| Stage2-vs-Stage4 |
5.127800E-01 |
| Stage3-vs-Stage4 |
9.505200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.921050E-01 |
| Normal-vs-AfricanAmerican |
9.677600E-01 |
| Normal-vs-Asian |
2.241500E-04 |
| Caucasian-vs-AfricanAmerican |
3.703200E-01 |
| Caucasian-vs-Asian |
3.133600E-02 |
| AfricanAmerican-vs-Asian |
5.201500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.297400E-01 |
| Normal-vs-Female |
1.221710E-02 |
| Male-vs-Female |
2.314300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.243400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.636200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.943800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.796600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.871800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.263800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.498000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.510100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.480400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.427800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.359720E-02 |
| Normal-vs-Grade 2 |
5.901900E-02 |
| Normal-vs-Grade 3 |
5.260400E-01 |
| Normal-vs-Grade 4 |
7.018000E-01 |
| Grade 1-vs-Grade 2 |
4.087600E-02 |
| Grade 1-vs-Grade 3 |
1.731820E-02 |
| Grade 1-vs-Grade 4 |
8.076500E-03 |
| Grade 2-vs-Grade 3 |
2.122400E-01 |
| Grade 2-vs-Grade 4 |
7.116000E-02 |
| Grade 3-vs-Grade 4 |
3.932800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.133640E-02 |
| Normal-vs-ccB subtype |
5.366400E-01 |
| ccA subtype-vs-ccB subtype |
7.594200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.311700E-02 |
| Normal-vs-N1 |
5.412400E-01 |
| N0-vs-N1 |
2.031400E-01 |
|
|
